FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021000736> ?p ?o ?g. }

• W3021000736 endingPage "379" @default.
• W3021000736 startingPage "371" @default.
• W3021000736 abstract "COVID-19 is an unprecedented challenge for physicians and scientists. Several publicized drugs are being used with not much evidence of their efficacy such as hydroxychloroquine, azithromycin or lopinavir-ritonavir. Yet, the cardiac safety of these drugs in COVID-19 deserves scrutiny as they are known to foster cardiac adverse ADRs, notably QTc interval prolongation on the electrocardiogram and its arrhythmogenic consequences. Since March 27th, 2020, the French Pharmacovigilance Network directed all cardiac adverse drug reactions associated with “off-label” use of hydroxychloroquine, azithromycin and lopinavir-ritonavir in COVID-19 to the Nice Regional Center of Pharmacovigilance. Each Regional Center of Pharmacovigilance first assessed causality of drugs. We performed a specific analysis of these cardiac adverse drug reactions amidst an array of risk factors, reassessed the electrocardiograms and estimated their incidence in coronavirus disease 2019. In one month, 120 reports of cardiac adverse drug reactions have been notified, 103 of which associated with hydroxychloroquine alone (86%), or associated with azithromycin (60%). Their estimated incidence is 0.77% to 1.54% of all patients, notwithstanding strong underreporting. Lopinavir-ritonavir came third with 17 reports (14%) and chloroquine fourth with 3 reports (2.5%). There were 8 sudden, unexplained or aborted deaths (7%), 8 ventricular arrhythmias (7%), 90 reports of prolonged QTc (75%) most of them “serious” (64%), 48 of which proved ≥ 500 ms, 20 reports of severe conduction disorders (17%) and 5 reports of other cardiac causes (4%). Six reports derived from automedication. “Off-label” use of treatments in COVID-19 increases the risk of cardiac ADRs, some of them avoidable. Even if these drugs are perceived as familiar, they are used in patients with added risk factors caused by infection. Precautions should be taken to mitigate the risk, even if they will be proven efficacious." @default.
• W3021000736 created "2020-05-13" @default.
• W3021000736 creator A5028601734 @default.
• W3021000736 creator A5036183476 @default.
• W3021000736 creator A5041668518 @default.
• W3021000736 creator A5044332540 @default.
• W3021000736 creator A5054135342 @default.
• W3021000736 creator A5069179814 @default.
• W3021000736 creator A5073427689 @default.
• W3021000736 creator A5080466425 @default.
• W3021000736 creator A5087887705 @default.
• W3021000736 date "2020-07-01" @default.
• W3021000736 modified "2023-10-17" @default.
• W3021000736 title "“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers" @default.
• W3021000736 cites W1898032589 @default.
• W3021000736 cites W1964015794 @default.
• W3021000736 cites W1968098810 @default.
• W3021000736 cites W1977227712 @default.
• W3021000736 cites W1983453280 @default.
• W3021000736 cites W1993220756 @default.
• W3021000736 cites W2009890917 @default.
• W3021000736 cites W2014746876 @default.
• W3021000736 cites W2095861052 @default.
• W3021000736 cites W2119425860 @default.
• W3021000736 cites W2150535358 @default.
• W3021000736 cites W2325205130 @default.
• W3021000736 cites W2588325901 @default.
• W3021000736 cites W2806330066 @default.
• W3021000736 cites W2890189169 @default.
• W3021000736 cites W2903385841 @default.
• W3021000736 cites W2977656194 @default.
• W3021000736 cites W3005212621 @default.
• W3021000736 cites W3007227604 @default.
• W3021000736 cites W3007610090 @default.
• W3021000736 cites W3008763357 @default.
• W3021000736 cites W3009828946 @default.
• W3021000736 cites W3010596635 @default.
• W3021000736 cites W3012379316 @default.
• W3021000736 cites W3012562222 @default.
• W3021000736 cites W3013899502 @default.
• W3021000736 cites W3014330135 @default.
• W3021000736 cites W3015201674 @default.
• W3021000736 cites W3015907249 @default.
• W3021000736 cites W3016690313 @default.
• W3021000736 cites W3017291809 @default.
• W3021000736 cites W3019049006 @default.
• W3021000736 cites W3020239101 @default.
• W3021000736 cites W3021745382 @default.
• W3021000736 cites W3217261033 @default.
• W3021000736 doi "https://doi.org/10.1016/j.therap.2020.05.002" @default.
• W3021000736 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7204701" @default.
• W3021000736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32418730" @default.
• W3021000736 hasPublicationYear "2020" @default.
• W3021000736 type Work @default.
• W3021000736 sameAs 3021000736 @default.
• W3021000736 citedByCount "91" @default.
• W3021000736 countsByYear W30210007362020 @default.
• W3021000736 countsByYear W30210007362021 @default.
• W3021000736 countsByYear W30210007362022 @default.
• W3021000736 countsByYear W30210007362023 @default.
• W3021000736 crossrefType "journal-article" @default.
• W3021000736 hasAuthorship W3021000736A5028601734 @default.
• W3021000736 hasAuthorship W3021000736A5036183476 @default.
• W3021000736 hasAuthorship W3021000736A5041668518 @default.
• W3021000736 hasAuthorship W3021000736A5044332540 @default.
• W3021000736 hasAuthorship W3021000736A5054135342 @default.
• W3021000736 hasAuthorship W3021000736A5069179814 @default.
• W3021000736 hasAuthorship W3021000736A5073427689 @default.
• W3021000736 hasAuthorship W3021000736A5080466425 @default.
• W3021000736 hasAuthorship W3021000736A5087887705 @default.
• W3021000736 hasBestOaLocation W30210007361 @default.
• W3021000736 hasConcept C118441451 @default.
• W3021000736 hasConcept C126322002 @default.
• W3021000736 hasConcept C142462285 @default.
• W3021000736 hasConcept C159047783 @default.
• W3021000736 hasConcept C197934379 @default.
• W3021000736 hasConcept C203014093 @default.
• W3021000736 hasConcept C2777182164 @default.
• W3021000736 hasConcept C2777425658 @default.
• W3021000736 hasConcept C2778048844 @default.
• W3021000736 hasConcept C2778907293 @default.
• W3021000736 hasConcept C2779123688 @default.
• W3021000736 hasConcept C2779134260 @default.
• W3021000736 hasConcept C2779298103 @default.
• W3021000736 hasConcept C2781392899 @default.
• W3021000736 hasConcept C2993143319 @default.
• W3021000736 hasConcept C3008058167 @default.
• W3021000736 hasConcept C3013748606 @default.
• W3021000736 hasConcept C501593827 @default.
• W3021000736 hasConcept C524204448 @default.
• W3021000736 hasConcept C57658597 @default.
• W3021000736 hasConcept C71924100 @default.
• W3021000736 hasConcept C86803240 @default.
• W3021000736 hasConcept C89423630 @default.
• W3021000736 hasConcept C98274493 @default.
• W3021000736 hasConceptScore W3021000736C118441451 @default.
• W3021000736 hasConceptScore W3021000736C126322002 @default.
• W3021000736 hasConceptScore W3021000736C142462285 @default.

• next